Shaly Engineering shares dropped by 14% due to increased raw material costs in West Asia, putting pressure on margins. In response, the company is planning to establish a new AED 130-150 million medical device facility in Abu Dhabi to expand its global reach by Q4 FY28.

Shaily Engineering Plastics is addressing capacity constraints due to increased demand for GLP-1 and semaglutide devices by planning an expansion. The Abu Dhabi facility will boost production capacity by 75 million units annually, expected by Q4 FY28. However, potential geopolitical risks may affect the execution timeline.